Registries, research and regrets: is the FDA’s post-marketing REMS process not adequately protecting patients?

Kachuck NJ. Registries, research and regrets: is the FDA’s post-marketing REMS process not adequately protecting patients?  Ther Adv Neurol Disord 2011

Advertisements